Author

Wangjun Yan

Institutions: Shanghai Medical College of Fudan University, Fudan University, Fudan University Shanghai Cancer Center

Observed institutions: Shanghai Medical College of Fudan University, Fudan University, Fudan University Shanghai Cancer Center

OpenAlex ID: A5153872011

Efficacy and safety of narlumosbart in combination with stereotactic body radiation therapy followed by first-line chemotherapy combined with immunotherapy in advanced driver gene-negative non-small cell lung cancer patients with bone metastases: a phase II, single-arm, single-centre clinical trial protocol

2026 · Jin Li, Nianlan Zhou, et al. · BMJ Open

Works count: 1

Citation count:

H-index:

I10-index: